Copyright Reports & Markets. All rights reserved.

Global Microscopic Polyangiitis (MPA) Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Microscopic Polyangiitis (MPA) Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Product
      • 1.4.2 Avacopan
      • 1.4.3 Immune Globulin
      • 1.4.4 Rituximab Biosimilar
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size
      • 2.1.1 Global Microscopic Polyangiitis (MPA) Treatment Revenue 2014-2025
      • 2.1.2 Global Microscopic Polyangiitis (MPA) Treatment Sales 2014-2025
    • 2.2 Microscopic Polyangiitis (MPA) Treatment Growth Rate by Regions
      • 2.2.1 Global Microscopic Polyangiitis (MPA) Treatment Sales by Regions
      • 2.2.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Microscopic Polyangiitis (MPA) Treatment Sales by Manufacturers
      • 3.1.1 Microscopic Polyangiitis (MPA) Treatment Sales by Manufacturers
      • 3.1.2 Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Microscopic Polyangiitis (MPA) Treatment Revenue by Manufacturers
      • 3.2.1 Microscopic Polyangiitis (MPA) Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Microscopic Polyangiitis (MPA) Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Microscopic Polyangiitis (MPA) Treatment Price by Manufacturers
    • 3.4 Microscopic Polyangiitis (MPA) Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Microscopic Polyangiitis (MPA) Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Microscopic Polyangiitis (MPA) Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Microscopic Polyangiitis (MPA) Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Microscopic Polyangiitis (MPA) Treatment Sales by Product
    • 4.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue by Product
    • 4.3 Microscopic Polyangiitis (MPA) Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Microscopic Polyangiitis (MPA) Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Microscopic Polyangiitis (MPA) Treatment by Countries
      • 6.1.1 North America Microscopic Polyangiitis (MPA) Treatment Sales by Countries
      • 6.1.2 North America Microscopic Polyangiitis (MPA) Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Microscopic Polyangiitis (MPA) Treatment by Product
    • 6.3 North America Microscopic Polyangiitis (MPA) Treatment by End User

    7 Europe

    • 7.1 Europe Microscopic Polyangiitis (MPA) Treatment by Countries
      • 7.1.1 Europe Microscopic Polyangiitis (MPA) Treatment Sales by Countries
      • 7.1.2 Europe Microscopic Polyangiitis (MPA) Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Microscopic Polyangiitis (MPA) Treatment by Product
    • 7.3 Europe Microscopic Polyangiitis (MPA) Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Microscopic Polyangiitis (MPA) Treatment by Countries
      • 8.1.1 Asia Pacific Microscopic Polyangiitis (MPA) Treatment Sales by Countries
      • 8.1.2 Asia Pacific Microscopic Polyangiitis (MPA) Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Microscopic Polyangiitis (MPA) Treatment by Product
    • 8.3 Asia Pacific Microscopic Polyangiitis (MPA) Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Microscopic Polyangiitis (MPA) Treatment by Countries
      • 9.1.1 Central & South America Microscopic Polyangiitis (MPA) Treatment Sales by Countries
      • 9.1.2 Central & South America Microscopic Polyangiitis (MPA) Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Microscopic Polyangiitis (MPA) Treatment by Product
    • 9.3 Central & South America Microscopic Polyangiitis (MPA) Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Microscopic Polyangiitis (MPA) Treatment by Countries
      • 10.1.1 Middle East and Africa Microscopic Polyangiitis (MPA) Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Microscopic Polyangiitis (MPA) Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Microscopic Polyangiitis (MPA) Treatment by Product
    • 10.3 Middle East and Africa Microscopic Polyangiitis (MPA) Treatment by End User

    11 Company Profiles

    • 11.1 Celltrion Inc
      • 11.1.1 Celltrion Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Products Offered
      • 11.1.5 Celltrion Inc Recent Development
    • 11.2 ChemoCentryx Inc
      • 11.2.1 ChemoCentryx Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Products Offered
      • 11.2.5 ChemoCentryx Inc Recent Development
    • 11.3 Sandoz International GmbH
      • 11.3.1 Sandoz International GmbH Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Products Offered
      • 11.3.5 Sandoz International GmbH Recent Development
    • 11.4 Teijin Pharma Ltd
      • 11.4.1 Teijin Pharma Ltd Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Products Offered
      • 11.4.5 Teijin Pharma Ltd Recent Development
    • 11.5 TTY Biopharm Company Ltd
      • 11.5.1 TTY Biopharm Company Ltd Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Products Offered
      • 11.5.5 TTY Biopharm Company Ltd Recent Development

    12 Future Forecast

    • 12.1 Microscopic Polyangiitis (MPA) Treatment Market Forecast by Regions
      • 12.1.1 Global Microscopic Polyangiitis (MPA) Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Microscopic Polyangiitis (MPA) Treatment Market Forecast by Product
      • 12.2.1 Global Microscopic Polyangiitis (MPA) Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Microscopic Polyangiitis (MPA) Treatment Market Forecast by End User
    • 12.4 North America Microscopic Polyangiitis (MPA) Treatment Forecast
    • 12.5 Europe Microscopic Polyangiitis (MPA) Treatment Forecast
    • 12.6 Asia Pacific Microscopic Polyangiitis (MPA) Treatment Forecast
    • 12.7 Central & South America Microscopic Polyangiitis (MPA) Treatment Forecast
    • 12.8 Middle East and Africa Microscopic Polyangiitis (MPA) Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Microscopic Polyangiitis (MPA) Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Microscopic Polyangiitis (MPA) Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Microscopic Polyangiitis (MPA) Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Microscopic Polyangiitis (MPA) Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Microscopic Polyangiitis (MPA) Treatment in these regions.
      This research report categorizes the global Microscopic Polyangiitis (MPA) Treatment market by top players/brands, region, type and end user. This report also studies the global Microscopic Polyangiitis (MPA) Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Celltrion Inc
      ChemoCentryx Inc
      Sandoz International GmbH
      Teijin Pharma Ltd
      TTY Biopharm Company Ltd

      Market size by Product
      Avacopan
      Immune Globulin
      Rituximab Biosimilar
      Others
      Market size by End User
      Hospital
      Clinic
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Microscopic Polyangiitis (MPA) Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Microscopic Polyangiitis (MPA) Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Microscopic Polyangiitis (MPA) Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Microscopic Polyangiitis (MPA) Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Microscopic Polyangiitis (MPA) Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Microscopic Polyangiitis (MPA) Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now